West Pharmaceutical Services Inc (NYSE:WST)
$ 331.66 3.07 (0.93%) Market Cap: 24.16 Bil Enterprise Value: 23.86 Bil PE Ratio: 43.75 PB Ratio: 9.03 GF Score: 95/100

Q4 2019 West Pharmaceutical Services Inc Earnings Call Transcript

Feb 13, 2020 / 02:00PM GMT
Release Date Price: $174.38 (+7.51%)
Operator

Ladies and gentlemen, thank you for standing by, and welcome to the Q4 2019 West Pharmaceutical Services Earnings Conference Call. (Operator Instructions) Please be advised that today's conference is being recorded. (Operator Instructions)

I would now like to hand the conference over to your speaker today, Quintin Lai, Vice President of Investor Relations. Thank you. Please go ahead, sir.

Quintin J. Lai
West Pharmaceutical Services - VP of Corporate Development, Strategy & IR

Thank you, Gigi. Good morning, and welcome to West's Fourth Quarter and Full Year 2019 Conference Call. We issued our financial results this morning and the release has been posted in the Investors section on the company's website located at www.westpharma.com. This morning, CEO, Eric Green; and CFO, Bernard Birkett, will review our results, provide an update on our business and present our financial outlook for the full year 2020. There is a slide presentation that accompanies today's call, and a copy of the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot